CRISPR, delivered.

Non-viral delivery enabling precise genome editing in the brain and beyond.

Editpep pioneers precise, non-viral delivery of CRISPR in vivo.

Our PERC™ platform unlocks genome editing in the brain, overcoming the limitations of viral and lipid delivery systems. Starting in the CNS. Extending beyond.

Potent. Safe. Scalable.

Delivering CRISPR as a functionalized biologic.

PERC: Peptide-based CRISPR Delivery
  • Potent In Vivo Efficacy

    High-efficiency editing in neurons and glia, with broad tissue distribution

  • Built for Safety

    Transient, non-viral delivery avoids integration, sustained expression, and immunogenicity

  • Cargo Agnostic

    Supports multiple CRISPR modalities, including Cas9, Cas12a, and base editors

  • Scalable & GMP-Ready

    Cargo-agnostic format that’s easy to manufacture, customize, and deploy

Highly efficient  genome editing in neurons in vivo, with broad distribution

Scalable

Transient

No Cargo Limit

Low COGs

Effector-agnostic

Scalable • Transient • No Cargo Limit • Low COGs • Effector-agnostic •